Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Psoriasis, Moderate to Severe”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02969018
What this trial is testing

Study To Evaluate Safety And Efficacy Of PF-06700841 In Subjects With Moderate To Severe Plaque Psoriasis

Who this might be right for
Chronic Plaque Psoriasis
Pfizer 212
Not applicableLooking for participantsNCT07370766
What this trial is testing

Impact of Tildrakizumab on Patient Reported Outcomes in Patients With Moderate-to-severe Psoriasis in Canada

Who this might be right for
Psoriasis (PsO)Moderate to Severe Psoriasis
Chronicle Academy 80
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07765628
What this trial is testing

HS-20118 to Evaluate the Efficacy and Safety in Participant With Moderate-to-Severe Plaque Psoriasis

Who this might be right for
Moderate to Severe Plaque Psoriasis
Jiangsu Hansoh Pharmaceutical Co., Ltd. 120
Not applicableActive Not RecruitingNCT03218488
What this trial is testing

A Safety Study of Ustekinumab in the Treatment of Pediatric Participants Aged 6 Years and Older With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Janssen-Cilag International NV 135
Early research (Phase 1)UnknownNCT02918123
What this trial is testing

Safety of FURESTEM-CD Inj. in Patients With Moderate to Severe Plaque-type Psoriasis

Who this might be right for
Psoriasis
Kang Stem Biotech Co., Ltd. 9
Large-scale testing (Phase 3)Study completedNCT01090427
What this trial is testing

The Safety and Efficacy of Ustekinumab in Adolescent Patients With Psoriasis (CADMUS)

Who this might be right for
Psoriasis
Janssen Research & Development, LLC 110
Large-scale testing (Phase 3)Study completedNCT04451720
What this trial is testing

Study of Subcutaneous Risankizumab Injection to Assess Change in Palmoplantar Pustulosis Area and Severity Index [PPPASI] in Adult Japanese Participants With Palmoplantar Pustulosis

Who this might be right for
Palmoplantar Pustulosis (PPP)
AbbVie 119
Early research (Phase 1)Study completedNCT01577550
What this trial is testing

Single Rising Dose Study of BI 655066 in Patients With Moderate and Severe Psoriasis

Who this might be right for
Psoriasis
AbbVie 39
Large-scale testing (Phase 3)Study completedNCT00626002
What this trial is testing

Open Label Continuation Study in Moderate to Severe Psoriasis

Who this might be right for
Moderate to Severe Plaque Psoriasis
AbbVie (prior sponsor, Abbott) 2,301
Large-scale testing (Phase 3)Ended earlyNCT01163253
What this trial is testing

A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Pfizer 2,867
Not applicableStudy completedNCT01262534
What this trial is testing

Assess the Clinical Profile of Patients in Spain With Moderate to Severe Psoriasis.

Who this might be right for
Psoriasis
Janssen-Cilag, S.A. 1,042
Testing effectiveness (Phase 2)Active Not RecruitingNCT06591273
What this trial is testing

Efficacy and Safety of Infliximab Biosimilar in Treatment of Moderate to Severe Psoriasis; A Single-arm Clinical Trial

Who this might be right for
Moderate to Severe Chronic Plaque Psoriasis
Services Institute of Medical Sciences, Pakistan 104
Testing effectiveness (Phase 2)Study completedNCT02622386
What this trial is testing

The Effect of Riboflavin on Moderate to Severe Plaque Type Psoriasis

Who this might be right for
Psoriasis
University of Michigan 23
Large-scale testing (Phase 3)Looking for participantsNCT07130604
What this trial is testing

Evaluate the Efficacy and Safety of D-2570 in Subjects With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
InventisBio Co., Ltd 390
Large-scale testing (Phase 3)Study completedNCT01640951
What this trial is testing

4 Year Extension Study of Efficacy and Safety of Secukinumab in Patients With Moderate to Severe Chronic Plaque-type Psoriasis

Who this might be right for
Moderate to Severe Chronic Plaque-Type Psoriasis
Novartis Pharmaceuticals 675
Post-approval studies (Phase 4)Study completedNCT00669214
What this trial is testing

Evaluate the Safety and Efficacy of Efalizumab in Adult Patients With Moderate to Severe Plaque Psoriasis With Involvement of the Scalp

Who this might be right for
Psoriasis
Genentech, Inc. 89
Large-scale testing (Phase 3)Study completedNCT00691964
What this trial is testing

Study Comparing the Efficacy and Safety of ABT-874 to Etanercept and Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
AbbVie (prior sponsor, Abbott) 347
Large-scale testing (Phase 3)Study completedNCT03849404
What this trial is testing

Efficacy, Safety, and Immunogenicity of AVT02 With Moderate-to-Severe Chronic Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Alvotech Swiss AG 413
Testing effectiveness (Phase 2)Study completedNCT06542614
What this trial is testing

Treatment of Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. 209
Post-approval studies (Phase 4)Study completedNCT01265823
What this trial is testing

Immediate Response With Adalimumab and Its Impact on Quality of Life and Other Comorbidity Factors in Patients With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
AbbVie (prior sponsor, Abbott) 150
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation